Ready to bridge the “valley of death” between your lab bench and patient impact?
Join PhDa and the PDA for Translating Science – CancerXcelerate 2026, a monthly hybrid series at Campus Gasthuisberg featuring global leaders from Pfizer, Flamingo Therapeutics, Roche, and Astrivax. We will dive into the diverse roles that make science translation possible:
- 9 April, 9h00, ON4-9thFloor Invention: Jeremy Gale (Pfizer) on global clinical portfolios
- 22 April, 17h00, ON5-8thFloor.404-28.08.184: Stephane Van Rooijen (Flamingo Therapeutics) on biotech career paths after a PhD
- 7 May, 16h00, ON4 Auditorium: Daniel Lafkas (Roche) on impactful discovery research
- 21 May, 16h00, ON5-8thFloor.404-28.08.184: Hanne Callewaert (Astrivax) on building a spin-off
These sessions include networking receptions and serve as the essential foundation for our intensive Interuniversity Innovation Bootcamp this October. It’s time to turn your research into reality—see you there!
Contact info: Marek<dot>Piprek<at>kuleuven<dot>be
